92 related articles for article (PubMed ID: 3806992)
1. [Determination of circulating immune complex levels by ELISA using F(ab')2 anti-C3 antibody].
Muratsugu M; Makino M
Rinsho Byori; 1986 Oct; Spec No 69():53-9. PubMed ID: 3806992
[No Abstract] [Full Text] [Related]
2. [The measurement of IgG class circulating immune complexes in liver diseases using F(ab')2 anti C3 ELISA].
Muratsugu M; Makino M; Kohda H; Sekiya C
Rinsho Byori; 1987 Dec; 35(12):1385-91. PubMed ID: 3502152
[No Abstract] [Full Text] [Related]
3. Detection of circulating immune complexes with polyethylene glycol precipitation F(ab')2 anti-C3 ELISA.
Xu RJ; Gu YA
J Immunol Methods; 1990 Dec; 135(1-2):225-31. PubMed ID: 2273258
[TBL] [Abstract][Full Text] [Related]
4. [The measurement of circulating immune complexes using anti-C3 antibody micro ELISA].
Hayashi S; Aochi H; Nagamine K; Oshida M; Kurata Y; Kawagoe H
Rinsho Byori; 1986 Dec; 34(12):1408-12. PubMed ID: 3560472
[No Abstract] [Full Text] [Related]
5. Stimulation of complement amplification by F(ab')(2)-containing immune complexes and naturally occurring anti-hinge antibodies, possible role in systemic inflammation.
Lutz HU; Fumia S
Autoimmun Rev; 2008 Jun; 7(6):508-13. PubMed ID: 18558371
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies.
Welfringer F; d'Athis P; Scherrmann JM; Hervé F
J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma levels of IgA-IgG immune complexes and anti-F(ab')2 antibodies in patients with type 2 (non insulin-dependent) diabetes mellitus and microangiopathy.
Casiglia D; Giardina E; Scarantino G; Triolo G
Diabetes Res; 1990 Dec; 15(4):195-200. PubMed ID: 2132409
[TBL] [Abstract][Full Text] [Related]
8. [A measurement of IgA-containing immune complexes by anti-C3 ELISA].
Tanaka M
Nihon Hifuka Gakkai Zasshi; 1986 Jul; 96(8):839-42. PubMed ID: 3784054
[No Abstract] [Full Text] [Related]
9. Modified anti-C3 immune complex assay which avoids interference by anti-F(ab')2 antibodies.
Fukuda K; Seino J; Kinoshita Y; Sudo K; Horigome I; Furuyama T; Yoshinaga K
Tohoku J Exp Med; 1985 Jul; 146(3):337-47. PubMed ID: 3931296
[TBL] [Abstract][Full Text] [Related]
10. Human F(ab')2-containing immune complexes together with anti-hinge natural antibodies stimulate complement amplification in vitro and in vivo.
Fumia S; Goede JS; Fischler M; Luginbühl A; Frick S; Fodor P; Lutz HU
Mol Immunol; 2008 May; 45(10):2951-61. PubMed ID: 18339427
[TBL] [Abstract][Full Text] [Related]
11. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.
Panush RS; Somberg LB; Katz P; Longley S
Diagn Immunol; 1983; 1(4):288-94. PubMed ID: 6388973
[TBL] [Abstract][Full Text] [Related]
12. Anti-F(ab')2 antibodies that interfere with interpretation of the anti-C3 assay for immune complexes in children with rheumatic diseases.
Olds LC; Miller JJ
Arthritis Rheum; 1984 Mar; 27(3):330-6. PubMed ID: 6704194
[TBL] [Abstract][Full Text] [Related]
13. Problems in the detection of complement-fixing immune complexes.
Rødahl E
Acta Pathol Microbiol Immunol Scand C; 1985 Jun; 93(3):125-30. PubMed ID: 3875968
[TBL] [Abstract][Full Text] [Related]
14. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
[TBL] [Abstract][Full Text] [Related]
15. Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.
Takata Y; Tamura N; Fujita T
J Immunol; 1984 May; 132(5):2531-7. PubMed ID: 6232320
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin production by human peripheral lymphocytes induced by anti-C3 receptor antibodies.
Daha MR; Bloem AC; Ballieux RE
J Immunol; 1984 Mar; 132(3):1197-1201. PubMed ID: 6229578
[TBL] [Abstract][Full Text] [Related]
17. Association of anti-F (ab')2 antibodies (pepsin agglutinators) with immune complexes as determined by enzyme-linked immunosorbent assays.
Davey MP; Korngold L
Int Arch Allergy Appl Immunol; 1982; 67(3):278-83. PubMed ID: 6977496
[TBL] [Abstract][Full Text] [Related]
18. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Vanes LA
Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
[TBL] [Abstract][Full Text] [Related]
19. Primary antibody-Fab fragment complexes: a flexible alternative to traditional direct and indirect immunolabeling techniques.
Brown JK; Pemberton AD; Wright SH; Miller HR
J Histochem Cytochem; 2004 Sep; 52(9):1219-30. PubMed ID: 15314089
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of circulating immune complexes in human serum by the Raji cell and F(ab')2 anti-C3 micro enzyme immunoassays.
Jordan SC; Gautier E; Sakai R; Bahn L
J Immunol Methods; 1985 Nov; 83(2):363-70. PubMed ID: 3902980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
